Watch the interview!
Disclaimer
This case report and/or content does not reflect the opinion of iHF or iheartfunction.com, nor does it engage their responsibility.
M-TEER: patient selection and timing in heart failure
Myocardial dysfunction & atrial disorders
Valve disease
Interview
Alexandre Mebazaa and Michael Böhm discuss the indications and timing of transcatheter mitral valve edge-to-edge repair (M-TEER) in this exclusive iHF 2026 interview.
In patients with heart failure and reduced ejection fraction, the presence of mitral regurgitation raises important questions about which patients truly benefit from intervention.
The discussion focuses on key decision factors, including the severity and clinical relevance of mitral regurgitation, technical feasibility, ventricular loading conditions, and patient stability to minimise peri-procedural risk.
It also explores the ongoing debate around patient selection criteria and the point at which intervention provides meaningful benefit beyond symptomatic improvement.
Examine the key decisions guiding M-TEER in heart failure!
